Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-10-31

FDA Approved: ROSUVASTATIN CALCIUM — Original Application (Cranbury Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved Cranbury Pharmaceuticals' rosuvastatin calcium through an Original Application for an Abbreviated New Drug Application (ANDA), enabling a generic r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ROSUVASTATIN CALCIUM (rosuvastatin calcium)

Snippet

ORIG AP for ROSUVASTATIN CALCIUM (ROSUVASTATIN CALCIUM)